Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0000899243-18-014478

Options or other derivatives

  • Chief Business Officer acquired 225,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
McVeigh Brian Chief Business Officer 2018-05-29 Grant or award · Stock Option (Right to Buy) +225,000 225,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…